Concepedia

A phase II study of palonosetron combined with dexamethasone to prevent nausea and vomiting induced by highly emetogenic chemotherapy

Makoto Maemondo, N Masuda, Ikuo Sekine, Kaoru Kubota, Yoshihiko Segawa, Masahiko Shibuya, Fumio Imamura, Nobuyuki Katakami, Toyoaki Hida, S. Takeo

Annals of Oncology · 2009 · 56 citations · 21 references

DOIFull text

Open access

Concepts

References

21

American Society of Clinical Oncology Guideline for Antiemetics in Oncology: Update 2006

Mark G. Kris, Paul J. Hesketh, Mark R. Somerfield et al. · Journal of Clinical Oncology · 2006 · 743 citations · Full text

, , +15

Delayed Nausea and Vomiting Continue to Reduce Patients' Quality of Life After Highly and Moderately Emetogenic Chemotherapy Despite Antiemetic Treatment

Brigitte Bloechl‐Daum, Robert Deuson, Panagiotis Mavros et al. · Journal of Clinical Oncology · 2006 · 505 citations

, , +17

Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron

Richard J. Gralla, M. Lichinitser, S. van der Vegt et al. · Annals of Oncology · 2003 · 471 citations

, , +17

Improved prevention of moderately emetogenic chemotherapy‐induced nausea and vomiting with palonosetron, a pharmacologically novel 5‐HT<sub>3</sub> receptor antagonist

Peter D. Eisenberg, Jazmin Figueroa‐Vadillo, Rosalio Zamora et al. · Cancer · 2003 · 404 citations · Full text

, , +17

A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy

Matti Aapro, Steven M. Grunberg, George Manikhas et al. · Annals of Oncology · 2006 · 340 citations · Full text

, , +16